/Investor DB

ESADE BAN — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Nanobots Therapeuticsnanobotstx.cominSep 2023

Nanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications.

BiotechDeep TechMedical Devices

Samuel Sánchezin

Co-investorsBStartupCapital Cell

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.